Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5–90 years
Joel Simrén(University of Gothenburg), Kaj Blennow(Sahlgrenska University Hospital), Christopher Gillberg(Sahlgrenska University Hospital), Elisabeth Fernell(University of Gothenburg), Marc Suárez Calvet(Pasqual Maragall Foundation), Ulf Andréasson(Sahlgrenska University Hospital), Roberta Ghidoni(Centro San Giovanni di Dio Fatebenefratelli), Lars Nyberg(Umeå University), Mats Johnson(Sahlgrenska University Hospital), Henrik Zetterberg(University of Wisconsin–Madison), Ingibjörg H. Jónsdóttir, Barbara Borroni(Centro San Giovanni di Dio Fatebenefratelli), Johan Gobom(Sahlgrenska University Hospital), Herman Depypere, Caroline Hansson(University of Gothenburg)
Cited by 187
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k